Fetal malformations of cortical development: review and clinical guidance - Report - MDSpire

Fetal malformations of cortical development: review and clinical guidance

  • By

  • Jeffrey B Russ

  • Sonika Agarwal

  • Charu Venkatesan

  • Barbara Scelsa

  • Brigitte Vollmer

  • Tomo Tarui

  • Andrea C Pardo

  • Monica E Lemmon

  • Sarah B Mulkey

  • Anthony R Hart

  • Usha D Nagaraj

  • Jeffrey A Kuller

  • Matthew T Whitehead

  • Jennifer L Cohen

  • Juliana S Gebb

  • Orit A Glenn

  • Mary E Norton

  • Dawn Gano

  • March 6, 2025

  • 0 min

Share

Clinical Report: Overview and Management of Malformations of Cortical Development

Overview

Malformations of cortical development (MCDs) are congenital brain anomalies arising from disrupted cerebral cortex development, often detected prenatally via genetic testing and imaging. These malformations are associated with significant pediatric morbidity including epilepsy, intellectual disability, and cerebral palsy. This report summarizes current understanding of cortical development, prenatal detection challenges, and clinical recommendations for managing MCDs.

Background

MCDs originate from genetic or secondary causes affecting neuronal proliferation, migration, and cortical organization, leading to heterogeneous brain malformations. Advances in antenatal genetic screening and fetal imaging have improved early diagnosis, yet prognostication remains difficult due to variability in malformation types and outcomes. Understanding the timeline of cortical development is crucial for interpreting imaging findings and guiding prenatal counseling. Clinicians face challenges in balancing the gravity of diagnosis with uncertainties in outcome prediction when advising families.

Data Highlights

Key developmental milestones include excitatory neurogenesis beginning at 6–8 weeks gestation, peak neuronal migration around 20–22 weeks, and cortical folding detectable on imaging from 18–20 weeks. Outer radial glia become predominant neurogenic precursors by 17 weeks. Corpus callosum axons cross the midline between 12 and 20 weeks. Inhibitory interneurons migrate tangentially from 20 weeks into the postnatal period.

Key Findings

  • MCDs result from disruptions in neuronal proliferation, migration, or cortical organization, with genetic and secondary etiologies.
  • Early cortical development stages (6–24 weeks gestation) are critical windows for malformation onset and detection.
  • Fetal MRI can detect primary sulci such as the Sylvian fissure from 18–20 weeks, aiding prenatal diagnosis.
  • Clinical outcomes vary widely, including epilepsy, intellectual disability, and cerebral palsy, complicating counseling.
  • Current literature lacks comprehensive data on prenatal evolution and long-term outcomes of MCDs.
  • Interdisciplinary care and tailored prenatal counseling are essential for managing pregnancies affected by MCDs.

Clinical Implications

Clinicians should integrate knowledge of cortical developmental timelines with advanced imaging and genetic testing to optimize prenatal diagnosis of MCDs. Counseling must address the heterogeneity of outcomes and uncertainties inherent in prognosis, guiding families through decisions about pregnancy management and delivery planning. Multidisciplinary collaboration is recommended to provide comprehensive care from the prenatal period onward.

Conclusion

Malformations of cortical development represent a complex group of congenital brain anomalies with significant clinical impact. Improved understanding of cortical development and advances in prenatal diagnostics support better management and counseling, though further research is needed to refine prognostication and therapeutic strategies.

References

  1. Review Article on MCDs -- Congenital Brain Malformations: An Overview of Cortical Development Disorders and Clinical Recommendations

Original Source(s)

Related Content